

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Pharmacological treatment and current controversies... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/8-1533/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/8-1533" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Pharmacological treatment and current controversies in COPD" />
    
            <meta name="og:title" content="F1000Research Article: Pharmacological treatment and current controversies in COPD.">
            <meta name="og:description" content="Read the latest article version by Mario Cazzola, Paola Rogliani, Daiana Stolz, Maria Gabriella Matera, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="21732">
            <meta name="article-id" content="19811">
            <meta name="dc.title" content="Pharmacological treatment and current controversies in COPD">
            <meta name="dc.description" content="Bronchodilators, corticosteroids, and antibiotics are still key elements for treating chronic obstructive pulmonary disease in the 2019 Global Initiative for Chronic Obstructive Lung Disease (GOLD) recommendations and this is due in part to our current inability to discover new drugs capable of decisively influencing the course of the disease. However, in recent years, information has been produced that, if used correctly, can allow us to improve the use of the available therapies.">
            <meta name="dc.subject" content="COPD; treatment; bronchodilators, inhaled corticosteroid">
            <meta name="dc.creator" content="Cazzola, Mario">
            <meta name="dc.creator" content="Rogliani, Paola">
            <meta name="dc.creator" content="Stolz, Daiana">
            <meta name="dc.creator" content="Matera, Maria Gabriella">
            <meta name="dc.date" content="2019/08/29">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.19811.1">
            <meta name="dc.source" content="F1000Research 2019 8:1533">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="COPD; treatment; bronchodilators">
            <meta name="prism.keyword" content="inhaled corticosteroid">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2019/08/29">
            <meta name="prism.volume" content="8">
            <meta name="prism.number" content="1533">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.19811.1">
            <meta name="prism.url" content="https://f1000research.com/articles/8-1533">
            <meta name="citation_title" content="Pharmacological treatment and current controversies in COPD">
            <meta name="citation_abstract" content="Bronchodilators, corticosteroids, and antibiotics are still key elements for treating chronic obstructive pulmonary disease in the 2019 Global Initiative for Chronic Obstructive Lung Disease (GOLD) recommendations and this is due in part to our current inability to discover new drugs capable of decisively influencing the course of the disease. However, in recent years, information has been produced that, if used correctly, can allow us to improve the use of the available therapies.">
            <meta name="citation_description" content="Bronchodilators, corticosteroids, and antibiotics are still key elements for treating chronic obstructive pulmonary disease in the 2019 Global Initiative for Chronic Obstructive Lung Disease (GOLD) recommendations and this is due in part to our current inability to discover new drugs capable of decisively influencing the course of the disease. However, in recent years, information has been produced that, if used correctly, can allow us to improve the use of the available therapies.">
            <meta name="citation_keywords" content="COPD; treatment; bronchodilators, inhaled corticosteroid">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Mario Cazzola">
            <meta name="citation_author_institution" content="Unit of Respiratory Medicine, Department of Experimental Medicine, University of Rome &quot;Tor Vergata&quot;, Rome, Italy">
            <meta name="citation_author" content="Paola Rogliani">
            <meta name="citation_author_institution" content="Unit of Respiratory Medicine, Department of Experimental Medicine, University of Rome &quot;Tor Vergata&quot;, Rome, Italy">
            <meta name="citation_author" content="Daiana Stolz">
            <meta name="citation_author_institution" content="Clinic of Respiratory Medicine and Pulmonary Cell Research, University Hospital of Basel, Basel, Switzerland">
            <meta name="citation_author" content="Maria Gabriella Matera">
            <meta name="citation_author_institution" content="Unit of Pharmacology, Department of Experimental Medicine, University of Campania &quot;Luigi Vanvitelli&quot;, Naples, Italy">
            <meta name="citation_publication_date" content="2019/08/29">
            <meta name="citation_volume" content="8">
            <meta name="citation_publication_number" content="1533">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.19811.1">
            <meta name="citation_firstpage" content="1533">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/8-1533/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/8-1533.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=21732 /> <input type=hidden id=articleId name=articleId value=19811 /> <input type=hidden id=xmlUrl value="/articles/8-1533/v1/xml"/> <input type=hidden id=xmlFileName value="-8-1533-v1.xml"> <input type=hidden id=article_uuid value=099d25f3-2c3b-4dfb-846f-f95ebe5d5b89 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Pharmacological treatment and current controversies in COPD"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.19811.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.19811.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/8-1533"
  },
  "headline": "Pharmacological treatment and current controversies in COPD",
  "datePublished": "2019-08-29T14:19:34",
  "dateModified": "2019-08-29T14:19:34",
  "author": [
    {
      "@type": "Person",
      "name": "Mario Cazzola"
    },    {
      "@type": "Person",
      "name": "Paola Rogliani"
    },    {
      "@type": "Person",
      "name": "Daiana Stolz"
    },    {
      "@type": "Person",
      "name": "Maria Gabriella Matera"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Bronchodilators, corticosteroids, and antibiotics are still key elements for treating chronic obstructive pulmonary disease in the 2019 Global Initiative for Chronic Obstructive Lung Disease (GOLD) recommendations and this is due in part to our current inability to discover new drugs capable of decisively influencing the course of the disease. However, in recent years, information has been produced that, if used correctly, can allow us to improve the use of the available therapies."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/8-1533/v1",
            "name": "Pharmacological treatment and current controversies in COPD"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Pharmacological treatment and current controversies in COPD </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=21732 data-id=19811 data-downloads="" data-views="" data-scholar="10.12688/f1000research.19811.1" data-recommended="" data-doi="10.12688/f1000research.19811.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/8-1533/v1/pdf?article_uuid=099d25f3-2c3b-4dfb-846f-f95ebe5d5b89" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-19811-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-19811-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-19811-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Cazzola M, Rogliani P, Stolz D and Matera MG. Pharmacological treatment and current controversies in COPD [version 1; peer review: 3 approved]</span>. <i>F1000Research</i> 2019, <b>8</b>(F1000 Faculty Rev):1533 (<a class=new-orange href="https://doi.org/10.12688/f1000research.19811.1" target=_blank>https://doi.org/10.12688/f1000research.19811.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-19811-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=19811 id=track-article-signin-19811 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/19811?target=/articles/8-1533/v1">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=21732 /> <input name=articleId type=hidden value=19811 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Pharmacological treatment and current controversies in COPD</h1><span class=other-info> [version 1; peer review: 3 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class=""><a href="mailto:mario.cazzola@uniroma2.it" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Mario Cazzola</span></a><a href="https://orcid.org/0000-0003-4895-9707" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-4895-9707</div><sup>1</sup>,&nbsp;</span><span class="">Paola Rogliani<sup>1</sup>,&nbsp;</span><span class="">Daiana Stolz<sup>2</sup>,&nbsp;</span><span class="">Maria Gabriella Matera<sup>3</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class=""><a href="mailto:mario.cazzola@uniroma2.it" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Mario Cazzola</span></a><a href="http://orcid.org/0000-0003-4895-9707" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-4895-9707</div><sup>1</sup>,&nbsp;</span><span class="">Paola Rogliani<sup>1</sup>,&nbsp;</span><span class="">Daiana Stolz<sup>2</sup>,&nbsp;</span><span class="">Maria Gabriella Matera<sup>3</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 29 Aug 2019 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.19811.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Unit of Respiratory Medicine, Department of Experimental Medicine, University of Rome &quot;Tor Vergata&quot;, Rome, Italy<br/> <sup>2</sup> Clinic of Respiratory Medicine and Pulmonary Cell Research, University Hospital of Basel, Basel, Switzerland<br/> <sup>3</sup> Unit of Pharmacology, Department of Experimental Medicine, University of Campania &quot;Luigi Vanvitelli&quot;, Naples, Italy<br/> <p> <div class=margin-bottom> Mario Cazzola <br/> <span>Roles: </span> Conceptualization, Writing – Original Draft Preparation </div> <div class=margin-bottom> Paola Rogliani <br/> <span>Roles: </span> Conceptualization, Writing – Review & Editing </div> <div class=margin-bottom> Daiana Stolz <br/> <span>Roles: </span> Conceptualization, Writing – Review & Editing </div> <div class=margin-bottom> Maria Gabriella Matera <br/> <span>Roles: </span> Conceptualization, Writing – Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=55794-52745></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=32565-52747></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=55793-52746></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Bronchodilators, corticosteroids, and antibiotics are still key elements for treating chronic obstructive pulmonary disease in the 2019 Global Initiative for Chronic Obstructive Lung Disease (GOLD) recommendations and this is due in part to our current inability to discover new drugs capable of decisively influencing the course of the disease. However, in recent years, information has been produced that, if used correctly, can allow us to improve the use of the available therapies. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> COPD; treatment; bronchodilators, inhaled corticosteroid </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Mario Cazzola (<a href="mailto:mario.cazzola@uniroma2.it">mario.cazzola@uniroma2.it</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Mario Cazzola </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> MC has participated as a faculty member and advisor in scientific meetings and courses under the sponsorship of Almirall, AstraZeneca, Biofutura, Boehringer Ingelheim, Chiesi Farmaceutici, GlaxoSmithKline, Lallemand, Menarini Group, Mundipharma, Novartis, Pfizer, Teva, Verona Pharma, and Zambon and is or has been a consultant to ABC Farmaceutici, AstraZeneca, Chiesi Farmaceutici, Edmond Pharma, Lallemand, Novartis, Ockham Biotech, Verona Pharma, and Zambon, and his department was funded by Almirall. DS has received research grants from the Swiss National Foundation, AstraZeneca AG, Pan Gas AG, Weinmann AG, Curetis AG, Boston Scientific AG, Circassia Pharmaceuticals, and Lungenliga Switzerland; received payment for lectures, advisory panels, or sponsorship to attend scientific meetings from Novartis AG, AstraZeneca AG, GSK AG, Roche AG, Zambon, Pfizer, and Schwabe Pharma AG; and is the current education council chair of the European Respiratory Society and immediate past president of the European Board for Accreditation in Pneumology and is the current GOLD representative for Switzerland. PR participated as a lecturer and advisor in scientific meetings and courses under the sponsorship of Almirall, AstraZeneca, Biofutura, Boehringer Ingelheim, Chiesi Farmaceutici, Edmond Pharma, GlaxoSmithKline, Menarini Group, Mundipharma, and Novartis, and her department was funded by Almirall, Boehringer Ingelheim, Chiesi Farmaceutici Novartis, and Zambon. MGM has participated as a lecturer and advisor in scientific meetings and courses under the sponsorship of Almirall, AstraZeneca, Boehringer Ingelheim, Chiesi Farmaceutici, GlaxoSmithKline, and Novartis and has been a consultant to ABC Farmaceutici and Chiesi Farmaceutici, and her department was funded by Novartis, Boehringer Ingelheim, Novartis, and Zambon. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2019 Cazzola M <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Cazzola M, Rogliani P, Stolz D and Matera MG. Pharmacological treatment and current controversies in COPD [version 1; peer review: 3 approved]</span>. <i>F1000Research</i> 2019, <b>8</b>(F1000 Faculty Rev):1533 (<a href="https://doi.org/10.12688/f1000research.19811.1" target=_blank>https://doi.org/10.12688/f1000research.19811.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 29 Aug 2019, <b>8</b>(F1000 Faculty Rev):1533 (<a href="https://doi.org/10.12688/f1000research.19811.1" target=_blank>https://doi.org/10.12688/f1000research.19811.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 29 Aug 2019, <b>8</b>(F1000 Faculty Rev):1533 (<a href="https://doi.org/10.12688/f1000research.19811.1" target=_blank>https://doi.org/10.12688/f1000research.19811.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d11674e191>Introduction</h2><p class="" id=d11674e194>In the last 20 years or so, the therapeutic approach to chronic obstructive pulmonary disease (COPD), which the World Health Organization defines as “a lung disease characterized by chronic obstruction of lung airflow that interferes with normal breathing and is not fully reversible”<sup><a href="#ref-1">1</a></sup>, has gradually changed with increasing use of a precision medicine approach because we have understood that COPD is a heterogeneous disease<sup><a href="#ref-2">2</a></sup>. However, it is becoming increasingly obvious that the current therapeutic approach does not meet all the needs of the patient with COPD; moreover, there is a necessity to identify the patient who best responds to the single class of drugs currently available and also to understand whether new specific combinations of drugs that are more costly and complex are really able to increase the number of patients who can actually take advantage of them<sup><a href="#ref-2">2</a></sup>.</p><p class="" id=d11674e209>In this article, we aim to discuss the evidence and rationale for the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2019 pharmacological treatment recommendations and the general questions that must to be answered in order to make the best use of bronchodilators in COPD, to define the benefits of combining long-acting bronchodilators versus monotherapy, to explain why triple therapy in COPD is a precision medicine opportunity, and to examine whether and when we can go beyond the GOLD recommendations.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d11674e215>Bronchodilators as key elements for treating chronic obstructive pulmonary disease</h2><p class="" id=d11674e218>Even in the 2019 GOLD recommendations, bronchodilators are key elements for treating COPD<sup><a href="#ref-3">3</a></sup>. The rationale for the use of bronchodilators lies in the mechanisms of bronchomotor tone control and the ability to interfere with them<sup><a href="#ref-4">4</a></sup>. There is a direct influence of the parasympathetic nerve (vagus) and an indirect sympathetic influence. This means that if we want to induce bronchodilation, we must block the activation of muscarinic receptors induced by acetylcholine (ACh) with a muscarinic antagonist or we must activate β<sub>2</sub> adrenoceptors (AR) by using β<sub>2</sub> agonists<sup><a href="#ref-5">5</a></sup>.</p><p class="" id=d11674e239>The site where a muscarinic antagonist or a β<sub>2</sub> agonist will act depends mainly on the different distribution of muscarinic receptors and β<sub>2</sub> ARs in the bronchial tree. There is a decrease in muscarinic receptor density and conversely an increase in the density of β<sub>2</sub> ARs from central airways to peripheral ones<sup><a href="#ref-6">6</a></sup>. However, whereas in the central airways there is a vagal innervation that involves the release of ACh and the consequent stimulation of M<sub>3</sub> muscarinic receptors present on smooth muscle, in peripheral airways this innervation is absent, but there are M<sub>3 </sub>muscarinic receptors that respond to ACh that is released directly at the epithelium level by the activation of choline acetyltransferase by inflammatory mediators. This is the so-called non-neuronal ACh<sup><a href="#ref-7">7</a></sup>. We have explored the influence of aclidinium, a muscarinic antagonist, and formoterol, a β<sub>2</sub> agonist, on the contractile tone of human segmental bronchi and on the luminal area of human bronchioles and we observed that both drugs are effective in both central and peripheral airways but that aclidinium is more effective in the central airways and formoterol in the peripheral ones<sup><a href="#ref-8">8</a></sup>.</p><p class="" id=d11674e273>However, if we consider the mechanism(s) that can cause an increase in contractility of medium bronchi in the patient with COPD, we soon realize that the intensified parasympathetic activity cannot be opposed by the weak sympathetic tone<sup><a href="#ref-9">9</a></sup>. The cross-talk induced by the activation of β<sub>2</sub> ARs and the inhibition of M<sub>3</sub> muscarinic receptors at the level of airway smooth muscle cell leads to a synergistic bronchorelaxant effect. Nevertheless, the cholinergic and adrenergic systems certainly influence each other at a post-synaptic and probably at a pre-synaptic level and these complicated interactions explain why combinations of bronchodilators are useful at least from a pharmacological point of view<sup><a href="#ref-10">10</a></sup>.</p><p class="" id=d11674e290>A systematic review with meta-analysis of dual bronchodilation with long-acting muscarinic antagonist/long-acting β<sub>2</sub> agonist (LAMA/LABA) fixed-dose combinations (FDCs) for the treatment of stable COPD documented that all LAMA/LABA combinations are always more efficient than the respective mono-components in terms of the increase in trough forced expiratory volume in 1 s (FEV<sub>1</sub>)<sup><a href="#ref-11">11</a></sup>. LAMA/LABA combinations also improve both transitional dyspnea index and quality of life as expressed by the St. George’s Respiratory Questionnaire scores. There is also evidence that LAMA/LABA FDCs prevent or delay exacerbations of COPD (ECOPDs) when compared with LAMA monotherapy<sup><a href="#ref-12">12</a></sup>. Several mechanisms explain why LABA/LAMA may decrease the frequency of ECOPDs<sup><a href="#ref-13">13</a></sup>. They can deflate lungs, which results in the stabilization of the airways and thus a decrease in the potential mechanical inflammatory stress; reduce the disproportionate mucus production with an increase in mucociliary clearance; and lower symptom severity. It seems likely that they also cause an anti-inflammatory effect, at least as evidenced <i>in vitro</i> and in animal models, but this has not yet been demonstrated in patients with COPD. </p><p class="" id=d11674e316>In effect, improvements in FEV<sub>1</sub>, as documented in translational studies, can be explained by a favorable pharmacological synergistic interaction between LAMA and LABA at the level of medium bronchi<sup><a href="#ref-14">14</a>,<a href="#ref-15">15</a></sup>. The synergistic interaction also occurs at the level of small airways<sup><a href="#ref-8">8</a>,<a href="#ref-16">16</a>,<a href="#ref-17">17</a></sup>, which leads to effective pulmonary desufflation, resulting in decreased dyspnea, enhanced exercise tolerance, and relief of symptoms. Finally, there is evidence that LAMA/LABA combinations inhibit the non-neuronal cholinergic system with a reduction in the release of ACh<sup><a href="#ref-16">16</a>,<a href="#ref-17">17</a></sup>, an effect that may explain the protective action against ECOPDs.</p><p class="" id=d11674e346>Although the 2019 GOLD recommendations suggest using LAMA/LABA only in highly symptomatic patients with a COPD Assessment Test score higher than 20 and a history of two or more moderate exacerbations or one severe exacerbation in the previous year<sup><a href="#ref-3">3</a></sup>, we firmly believe that it is useful to start treating COPD with dual bronchodilation from the time of the first diagnosis in order to optimize bronchodilation while interfering with the pathways that influenc airway tone<sup><a href="#ref-18">18</a></sup>. At present, we must administer the currently approved doses for treating COPD, but we are confident that the documented pharmacological synergism of action between LAMA and LABA should lead to verifying whether lower dosages can be equally effective. If, as we believe, this approach will be positive, we will certainly succeed in reducing the risk of adverse events that characterize both LAMAs and LABAs when they are taken at the full doses currently approved for the treatment of COPD while satisfying the need to optimize bronchodilation.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d11674e360>Adding an inhaled corticosteroid</h2><p class="" id=d11674e363>Since there is evidence that inhaled corticosteroid/LABA (ICS/LABA) FDCs decrease ECOPD rates compared with placebo<sup><a href="#ref-19">19</a></sup> and LABA alone<sup><a href="#ref-20">20</a></sup> (although other data do not support this benefit<sup><a href="#ref-21">21</a></sup>), great emphasis is given to the use of ICS/LABA combinations in individuals with blood eosinophils of ≥300 cells·µL<sup><b>−1</b></sup> (as this value could allow to appreciate patients with a higher probability of taking advantage from ICS treatment) or in high-risk patients with a history of two or more moderate exacerbations or one severe exacerbation in the previous year at &gt;100 eosinophils·µL<sup><b>−1</b></sup><sup><a href="#ref-3">3</a></sup>. Patients with &lt;100 blood eosinophils·µL<sup><b>−1</b></sup> should not receive ICSs unless they are also asthmatic since this value suggests that these drugs will probably not be able to prevent ECOPDs<sup><a href="#ref-22">22</a></sup>. The real problem is represented by the group of patients with 100 to 300 eosinophils·µL<sup><b>−1</b></sup>, for whom there is still no solid evidence that allows us to formulate a consistent recommendation; therefore, the decision of whether to add an ICS should be based on individual considerations of probable benefits and possible risks<sup><a href="#ref-22">22</a></sup>.</p><p class="" id=d11674e406>There is a useful pharmacological interaction between corticosteroids and LABAs that may explain why adding ICS to LABA in patients with COPD is convenient<sup><a href="#ref-23">23</a></sup>. Corticosteroids increase the numbers of β<sub>2</sub> ARs, whereas β<sub>2</sub> agonists induce direct bronchodilation and increase glucocorticoid receptor (GR) nuclear translocation in the presence of corticosteroids, an effect that enhances the anti-inflammatory effects of corticosteroids and also occurs in COPD macrophages that are quite resistant to corticosteroids.</p><p class="" id=d11674e419>The importance of the ICS/LABA combination also lies in its ability to influence the multicomponent nature of COPD in a much more incisive way than just ICS or LABA alone, thanks to its ability to additively influence the COPD pathophysiology with direct actions on airway obstruction, inflammation, structural changes, and mucociliary dysfunction<sup><a href="#ref-24">24</a></sup>.</p><p class="" id=d11674e426>However, we recently documented that the beclomethasone dipropionate/formoterol furoate combination is able to synergistically relax human bronchi with a consistent effect at low to medium concentrations in small airways, mainly when they have been passively sensitized<sup><a href="#ref-25">25</a></sup>. This finding indicates the usefulness of the ICS/LABA combination in the treatment of asthma rather than COPD.</p><p class="" id=d11674e434>There is evidence that LAMA/LABA FDCs, at least glycopyrronium/indacaterol, prevent or delay ECOPDs when compared with ICS/LABA FDCs<sup><a href="#ref-26">26</a></sup>. Unquestionably, the signal generated by the FLAME (Effect of Indacaterol Glycopyrronium Versus Fluticasone Salmeterol on COPD Exacerbations) study, which showed that indacaterol/glycopyrronium was more effective than salmeterol/fluticasone in preventing ECOPDs, is important and suggests the possibility of interrupting the intake of ICS by patients with COPD. However, we still need a cautious approach because we still have doubts regarding COPD patients who can benefit from therapy with ICSs and the fact that double bronchodilation is better than triple therapy (LAMA/LABA/ICS) in the event that the addition of an ICS to the LAMA/LABA combination induces further clinical benefit<sup><a href="#ref-27">27</a></sup>.</p><p class="" id=d11674e445>A practical reason to use ICS-containing triple therapy instead of dual bronchodilation is that triple therapy could reduce all-cause mortality, as demonstrated in the IMPACT (Informing the Pathway of COPD Treatment) trial<sup><a href="#ref-28">28</a></sup>, although there are doubts that this actually happens. In fact, the study was not statistically powered for this outcome; in any case, as highlighted by Agusti and colleagues<sup><a href="#ref-22">22</a></sup>, this finding may have been influenced by the study’s possible enrollment of patients with a history of asthma. Furthermore, when the number of fatal events induced by the presence of ICS was compared with that observed in the absence of such drugs in a post hoc analysis of the aggregated data of the TRILOGY (Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β<sub>2</sub> agonist therapy for chronic obstructive pulmonary disease), TRINITY (Single Inhaler Extrafine Triple Therapy versus Long-Acting Muscarinic Antagonist Therapy for Chronic Obstructive Pulmonary Disease), and TRIBUTE (Extrafine Inhaled Triple Therapy versus Dual Bronchodilator Therapy in Chronic Obstructive Pulmonary Disease) trials, the reduction of the risk ratio of fatal events for treatments with ICS compared with treatments without ICS was not statistically significant<sup><a href="#ref-29">29</a></sup>.</p><p class="" id=d11674e463>In any case, stepping-up from dual bronchodilation to triple therapy, an approach that has also been proposed by the 2019 GOLD recommendations<sup><a href="#ref-3">3</a></sup>, deliberately ignores the fundamental differences in etiology, severity, and biological substrate of ECOPDs and consequently is not intended to treat the real needs of the patient<sup><a href="#ref-30">30</a></sup>. It is important to determine whether and when the addition of an ICS to the LAMA/LABA combination really induces further clinical benefit, regardless of a preventive effect on ECOPDs, and establish the value of this benefit and also determine whether cost differences make the LAMA/LABA combination therapy preferable over triple therapy in real life.</p><p class="" id=d11674e474>We performed a systematic review and meta-analysis to compare the impact of LAMA/LABA/ICS<i></i> versus LAMA/LABA combination therapy or single long-acting bronchodilator therapy in COPD<sup><a href="#ref-31">31</a></sup>. If the outcome was the risk of moderate or severe ECOPDs or the change from baseline in trough FEV<sub>1</sub>, LAMA/LABA/ICS resulted in significantly better outcomes than LAMA/LABA and single long-acting bronchodilator, whereas when the analysis was focused on the risk of pneumonia, no significant differences were observed. However, the person-based number needed to treat (NNT) per year of LAMA/LABA/ICS combination compared with LAMA/LABA combination was significantly lower in patients with ≥300 blood eosinophils·µL<sup><b>−1</b></sup> than in those with &lt;300 eosinophils·µL<sup><b>−1</b></sup>. In fact, the NNT to prevent one ECOPD over 1 year was only 8 to 10 patients for those with blood eosinophil counts of at ≥300 cells·µL<sup><b>−1</b></sup> but was about 47 for those with blood eosinophil counts &lt;300 cells·µL<sup><b>−1</b></sup>, a number that is likely to be unacceptable for most clinicians<sup><a href="#ref-32">32</a></sup>. If pneumonia is considered as the outcome, the person-based number needed to harm (NNH) of LAMA/LABA/ICS combination therapy versus LAMA/LABA combination therapy was 195.34 (95% confidence interval (CI) 85.06–∞) but diminished to 33.89 (95% CI 30.69–37.84) when the only randomized controlled trial that included fluticasone furoate in the triple combination was analyzed. </p><p class="" id=d11674e507>The valuation of the effect of triple therapy versus ICS/LABA combination on relevant outcomes in patients with COPD is another critical issue. In a different meta-analysis<sup><a href="#ref-33">33</a></sup>, we documented that, compared with ICS/LABA combination, LAMA/LABA/ICS combination significantly improved the trough FEV<sub>1</sub> from baseline, protected against the risk of moderate or severe ECOPDs, an effect that was not related with the eosinophil level, and did not increase the risk of cardiovascular severe acute events. </p><p class="" id=d11674e517>The evidence generated by our meta-analyses on triple therapy suggests that adding an ICS to a LAMA/LABA combination provides modest clinical benefit in the general COPD population, although the effect in the subgroup of patients with eosinophilia is of clinical relevance. Conversely, adding a LAMA to an ICS/LABA combination elicits relevant clinical benefit in the general COPD population, supporting the central role of dual bronchodilation therapy for the treatment of COPD.</p><p class="" id=d11674e521>Considering the evidence generated by our meta-analyses, we have reached the conviction that in the general COPD population, while the addition of an ICS to a LAMA/LABA combination provides a modest clinical benefit, the addition of a LAMA to an ICS/LABA combination elicits a significant clinical benefit unless the patient presents significant blood eosinophilia. In our opinion, this finding indicates the fundamental role of dual bronchodilation therapy for the treatment of COPD.</p><p class="" id=d11674e524>The DYNAGITO (Tiotropium and olodaterol in the prevention of chronic obstructive pulmonary disease exacerbations) study, which evaluated tiotropium and olodaterol in the prevention of ECOPDs, documented that the tiotropium/olodaterol FDC did not influence the exacerbation rate compared with tiotropium alone<sup><a href="#ref-34">34</a></sup>. In our opinion, a major issue biased the study. The majority of patients (70%) were taking an ICS at baseline<sup><a href="#ref-35">35</a></sup>. Patients taking an ICS at baseline did not stop this treatment. This means that a huge number of individuals in the LAMA/LABA group received triple combination therapy (tiotropium/olodaterol plus ICS) whereas those in the tiotropium group actually received tiotropium plus ICS. We believe that the results of this study suggest that tiotropium combined with an ICS is almost as effective as the tiotropium/olodaterol plus ICS combination in lowering the ECOPD risk. Therefore, an ICS/LAMA combination might be considered an option for treating COPD in patients with a history of ECOPDs.</p><p class="" id=d11674e535>However, we investigated the pharmacological interaction between beclomethasone dipropionate and glycopyrronium on human airway smooth muscle tone and showed that the combination of these two drugs synergistically increased the relaxation of passively sensitized medium and small bronchi, an effect that was not found in non-sensitized bronchi<sup><a href="#ref-36">36</a></sup>. The synergistic interaction effect was related to a rise in cAMP concentrations. These findings suggest that ICS/LAMA should be considered a useful therapy for most patients with asthma rather than patients with COPD.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d11674e545>Further therapeutic options</h2><p class="" id=d11674e548>The 2019 GOLD recommendations suggest adding roflumilast when the response to LAMA/LABA/ICS therapy is not satisfactory in patients with a FEV<sub>1</sub> of &lt;50% and chronic bronchitis<sup><a href="#ref-3">3</a></sup>. In effect, the REACT (Roflumilast in the Prevention of COPD Exacerbations While Taking Appropriate Combination Treatment) study documented that roflumilast causes a reduction in ECOPDs and hospitalizations in patients with severe COPD and chronic bronchitis who had at least two ECOPDs in the previous year despite triple therapy<sup><a href="#ref-37">37</a></sup>. At present, roflumilast is the only phosphodiesterase 4 (PDE<sub>4</sub>) inhibitor that has received marketing approval as a maintenance treatment in patients with COPD. However, it increases the risk of adverse events, mainly gastrointestinal side effects, but also induces headache, back pain, and insomnia<sup><a href="#ref-38">38</a></sup>. Therefore, it is always crucial to identify not only the right clinical COPD phenotype but also the right type of biological ECOPDs in the hope that, in this way, the use of roflumilast will induce benefits that far outweigh the possible risks<sup><a href="#ref-39">39</a></sup>. However, to create further confusion, there is the recent documentation that roflumilast was unable to impact the number of CD8 cells in bronchial submucosa compared with placebo after 16-week treatment but it reduced the eosinophil count in the airways, which suggests the hypothesis that the benefits of roflumilast in COPD could be due to an effect on lung eosinophils<sup><a href="#ref-40">40</a></sup>.</p><p class="" id=d11674e578>Also, theophylline is a PDE inhibitor but is non-selective. At the conventional doses, it is a weak bronchodilator but it is impossible to increase the dose owing to the risk of adverse effects that can also be severe<sup><a href="#ref-41">41</a></sup>. Nonetheless, at low concentrations, theophylline causes anti-inflammatory effects in COPD and also enhances histone deacetylase 2 activity, reversing corticosteroid resistance in COPD and further reducing inflammation<sup><a href="#ref-41">41</a></sup>. However, there is evidence generated by a meta-analysis of seven observational studies that theophylline increases, albeit marginally, deaths from all causes in patients with COPD<sup><a href="#ref-42">42</a></sup>. This information should not be overlooked when prescribing theophylline, at least in some patients with COPD.</p><p class="" id=d11674e593>Doxofylline differs from theophylline in the pharmacological profile and for this reason should not be considered a modified theophylline<sup><a href="#ref-43">43</a></sup>. Apparently, there are no substantial differences in regard to the changes in FEV<sub>1</sub> from baseline between doxofylline, aminophylline, and theophylline, which are all more effective than bamiphylline<sup><a href="#ref-44">44</a></sup>. In contrast, doxofylline, similarly to bamiphylline, appears to be much safer than aminophylline and theophylline. Consequently, we support the use of doxofylline, especially in those patients with COPD who have difficulties in using inhalers or who are not adequately controlled from other pharmacological classes because it is a safe, effective, and relatively inexpensive drug.</p><p class="" id=d11674e607>The 2019 GOLD recommendations suggest adding azithromycin as an alternative to roflumilast in former smokers<sup><a href="#ref-3">3</a></sup>. There is evidence that macrolides reduce inflammation and cellular damage in the inflamed airway with different actions not related to antimicrobial activity that seem to be polymodal and mainly due to inhibition of the transcription factors regulating the inflammatory pathways<sup><a href="#ref-45">45</a></sup>. Chronic treatment with erythromycin or azithromycin could effectively reduce the ECOPD rate but may cause increased adverse events and an increase in macrolide-resistant bacteria<sup><a href="#ref-46">46</a></sup>. We are definitely against such use of antibiotics, mainly because the approach is too general and does not consider the uniqueness of the subject receiving treatment and therefore is unsuitable for satisfying the individual needs of the patient<sup><a href="#ref-47">47</a></sup>. In fact, microanatomical geographic variations in bacterial composition, dependent on the location of the tissue sampling, may exist within the same diseased lung, and the composition of the lung microbiome is influenced by smoking, severity of COPD, ECOPDs, and use of steroids or antibiotics (or both). Furthermore, increasing evidence supports the role of changes in the composition of the microbial community outside of the lung (for example, intestinal and skin microbiota) in modulating chronic lung disorders and respiratory infections.</p><p class="" id=d11674e627>GOLD also recommends using mucolytic and anti-oxidant agents (N-acetylcysteine, carbocysteine, and erdosteine) because a long-term treatment with these drugs may reduce ECOPDs and cause a small improvement in health status in patients who are not receiving ICS therapy<sup><a href="#ref-3">3</a></sup>. This rank of effectiveness was provided by a recent network meta-analysis: erdosteine &gt; carbocysteine &gt; N-acetylcysteine<sup><a href="#ref-48">48</a></sup>. Only erdosteine reduced the risk of experiencing at least one ECOPD and the risk of hospitalization due to ECOPDs. Erdosteine and N-acetylcysteine significantly reduced the duration of ECOPDs.</p><p class="" id=d11674e638>These agents, which are thiol-containing drugs, act also as anti-oxidant and anti-inflammatory agents, are able to modulate human bronchial tone, and elicit anti-infective activity linked to their ability to reduce bacterial adhesion to surfaces and disrupt mature biofilms, an effect that improves the efficacy of antibiotic therapy<sup><a href="#ref-49">49</a></sup>.</p><p class="" id=d11674e645>Oxidative stress triggered by inhaled external oxidants or produced from endogenous sources can cause a reduction in natural anti-oxidants<sup><a href="#ref-50">50</a></sup>. When oxidants exceed endogenous anti-oxidants, several cellular processes are activated and generate cellular and molecular events that are considered to play a role in the pathogenesis of COPD. There is preclinical evidence that N-acetylcysteine, when tested at high concentrations, is effective in modulating the damaging effect induced by lipopolysaccharide during an ECOPD because it elicits both anti-oxidant and anti-inflammatory effects<sup><a href="#ref-51">51</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d11674e659>Conclusions</h2><p class="" id=d11674e662>We must be grateful to GOLD for helping doctors to understand the importance of COPD and for stimulating the scientific community’s interest in improving the diagnostic/therapeutic approach to this disorder, but we are trapped with the use of bronchodilators, corticosteroids, and antibiotics. It is likely that this is due to the fact that these classes of drug are able to reduce symptoms and often the risk of ECOPDs in many patients. However, it is also true that their use allows the typical “one size fits all” attitude, which makes the choice of treatment for the patient with COPD easier and for this reason it is still preferred by many doctors. On the other hand, we cannot exclude that it is also due to the fact that we are not yet able to identify new effective therapeutics<sup><a href="#ref-52">52</a></sup>.</p><p class="" id=d11674e669>Regrettably, the “one size fits all” approach that considers only symptoms and risk of exacerbations is insufficient to treat COPD. Therefore, we firmly believe that it is correct to go beyond the recommendations GOLD<sup><a href="#ref-2">2</a>,<a href="#ref-53">53</a>,<a href="#ref-54">54</a></sup>.</p><p class="" id=d11674e682>In recent years, considerable efforts have been made to identify new therapeutic approaches. In particular, investigators have tested whether monoclonal antibodies directed against cytokines and chemokines or their receptors could be useful in reducing the inflammatory component of COPD<sup><a href="#ref-55">55</a></sup>. Trials with tumor necrosis factor-alpha inhibitors or antagonists of interleukin 1 beta (IL-1β), IL-5, CXCL8 (IL-8), IL-3, or IL-17 have shown little or no therapeutic effect. We believe that this lack of therapeutic effect reflects the complexity of COPD in which there is no dominant cytokine or chemokine. Therefore, it is imperative to test these monoclonal antibodies in well-identified specific endotypes in which some of these cytokines or chemokines could prevail, such as eosinophilic COPD<sup><a href="#ref-55">55</a></sup>. In any case, these treatments will be reserved for a very limited number of patients.</p><p class="" id=d11674e693>A new and more practical approach could be the identification of tractable traits<sup><a href="#ref-56">56</a></sup>. For example, it has been suggested that, at least in primary care, the focus of therapy could be on the two major treatable traits in patients with airway disease: eosinophilic airway inflammation and airflow limitation<sup><a href="#ref-57">57</a></sup>. The focus should be on the risk of exacerbations as a result of eosinophilic airway inflammation and symptoms due to airflow limitation. However, if we still wish to follow GOLD recommendations, we must improve the use of the available therapies because we still have fundamental questions regarding their use. In any case, in recent years, information has been produced that, if used correctly, can allow us to improve the utilization of the available therapies<sup><a href="#ref-58">58</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d11674e712>Abbreviations</h2><p class="" id=d11674e715>ACh, acetylcholine; AR, adrenoceptor; CI, confidence interval; COPD, chronic obstructive pulmonary disease; ECOPD, exacerbation of chronic obstructive pulmonary disease; FDC, fixed-dose combination; FEV<sub>1</sub>, forced expiratory volume in 1 s; GOLD, Global Initiative for Chronic Obstructive Lung Disease; ICS, inhaled corticosteroid; IL, interleukin; LABA, long-acting β<sub>2</sub> agonist; LAMA, long-acting muscarinic antagonist; NNT, number needed to treat; PDE, phosphodiesterase</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d11674e1 class=n-a></a><h2 class=main-title id=d11850>Grant information</h2><p>The author(s) declared that no grants were involved in supporting this work.</p></div><div class=back-section><a name=d11674e728 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d12034>References</h2><div class="section ref-list"><a name=d11674e728 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d11674e735 class=n-a></a>World Health Organization: Chronic obstructive pulmonary disease (COPD). <a target=xrefwindow id=d11674e737 href="https://www.who.int/respiratory/copd/en/">Reference Source</a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d11674e746 class=n-a></a>Cazzola M, Rogliani P, Puxeddu E, <i> et al.</i>: An overview of the current management of chronic obstructive pulmonary disease: can we go beyond the GOLD recommendations? <i>Expert Rev Respir Med.</i> 2018; <b>12</b>(1): 43–54. <a target=xrefwindow id=d11674e757 href="http://www.ncbi.nlm.nih.gov/pubmed/29082808">PubMed Abstract </a> | <a target=xrefwindow id=d11674e760 href="https://doi.org/10.1080/17476348.2018.1398086">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d11674e769 class=n-a></a>Global Initiative for Chronic Obstructive Lung Disease: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease; [updated 2019]. <a target=xrefwindow id=d11674e771 href="https://goldcopd.org/wp-content/uploads/2018/11/GOLD-2019-v1.5-FINAL-04Nov2018_WMS.pdf">Reference Source</a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d11674e780 class=n-a></a>Cazzola M, Page CP, Calzetta L, <i> et al.</i>: Pharmacology and therapeutics of bronchodilators. <i>Pharmacol Rev.</i> 2012; <b>64</b>(3): 450–504. <a target=xrefwindow id=d11674e791 href="http://www.ncbi.nlm.nih.gov/pubmed/22611179">PubMed Abstract </a> | <a target=xrefwindow id=d11674e794 href="https://doi.org/10.1124/pr.111.004580">Publisher Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725733769"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11674e803 class=n-a></a>Panettieri RA Jr: Bronchodilators, receptors and cross-talk: Together is better? <i>Postgrad Med.</i> 2015; <b>127</b>(7): 771–80. <a target=xrefwindow id=d11674e811 href="http://www.ncbi.nlm.nih.gov/pubmed/26293997">PubMed Abstract </a> | <a target=xrefwindow id=d11674e814 href="https://doi.org/10.1080/00325481.2015.1080589">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725733769">F1000 Recommendation</a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d11674e828 class=n-a></a>Ikeda T, Anisuzzaman AS, Yoshiki H, <i> et al.</i>: Regional quantification of muscarinic acetylcholine receptors and β-adrenoceptors in human airways. <i>Br J Pharmacol.</i> 2012; <b>166</b>(6): 1804–14. <a target=xrefwindow id=d11674e839 href="http://www.ncbi.nlm.nih.gov/pubmed/22300233">PubMed Abstract </a> | <a target=xrefwindow id=d11674e842 href="https://doi.org/10.1111/j.1476-5381.2012.01881.x">Publisher Full Text </a> | <a target=xrefwindow id=d11674e846 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3402805">Free Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d11674e855 class=n-a></a>Barnes PJ: Distribution of receptor targets in the lung. <i>Proc Am Thorac Soc.</i> 2004; <b>1</b>(4): 345–51. <a target=xrefwindow id=d11674e863 href="http://www.ncbi.nlm.nih.gov/pubmed/16113456">PubMed Abstract </a> | <a target=xrefwindow id=d11674e866 href="https://doi.org/10.1513/pats.200409-045MS">Publisher Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d11674e875 class=n-a></a>Cazzola M, Calzetta L, Page CP, <i> et al.</i>: Pharmacological characterization of the interaction between aclidinium bromide and formoterol fumarate on human isolated bronchi. <i>Eur J Pharmacol.</i> 2014; <b>745</b>: 135–43. <a target=xrefwindow id=d11674e886 href="http://www.ncbi.nlm.nih.gov/pubmed/25446566">PubMed Abstract </a> | <a target=xrefwindow id=d11674e889 href="https://doi.org/10.1016/j.ejphar.2014.10.025">Publisher Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d11674e898 class=n-a></a>Calzetta L, Matera MG, Cazzola M: Pharmacological mechanisms leading to synergy in fixed-dose dual bronchodilator therapy. <i>Curr Opin Pharmacol.</i> 2018; <b>40</b>: 95–103. <a target=xrefwindow id=d11674e906 href="http://www.ncbi.nlm.nih.gov/pubmed/29626716">PubMed Abstract </a> | <a target=xrefwindow id=d11674e909 href="https://doi.org/10.1016/j.coph.2018.03.011">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d11674e918 class=n-a></a>Calzetta L, Matera MG, Cazzola M: Pharmacological interaction between LABAs and LAMAs in the airways: optimizing synergy. <i>Eur J Pharmacol.</i> 2015; <b>761</b>: 168–73. <a target=xrefwindow id=d11674e926 href="http://www.ncbi.nlm.nih.gov/pubmed/25981302">PubMed Abstract </a> | <a target=xrefwindow id=d11674e929 href="https://doi.org/10.1016/j.ejphar.2015.05.020">Publisher Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d11674e938 class=n-a></a>Calzetta L, Rogliani P, Matera MG, <i> et al.</i>: A Systematic Review With Meta-Analysis of Dual Bronchodilation With LAMA/LABA for the Treatment of Stable COPD. <i>Chest.</i> 2016; <b>149</b>(5): 1181–96. <a target=xrefwindow id=d11674e949 href="http://www.ncbi.nlm.nih.gov/pubmed/26923629">PubMed Abstract </a> | <a target=xrefwindow id=d11674e952 href="https://doi.org/10.1016/j.chest.2016.02.646">Publisher Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d11674e962 class=n-a></a>Wedzicha JA, Decramer M, Ficker JH, <i> et al.</i>: Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study. <i>Lancet Respir Med.</i> 2013; <b>1</b>(3): 199–209. <a target=xrefwindow id=d11674e973 href="http://www.ncbi.nlm.nih.gov/pubmed/24429126">PubMed Abstract </a> | <a target=xrefwindow id=d11674e976 href="https://doi.org/10.1016/S2213-2600(13)70052-3">Publisher Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727083151"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11674e985 class=n-a></a>Beeh KM, Burgel PR, Franssen FME, <i> et al.</i>: How Do Dual Long-Acting Bronchodilators Prevent Exacerbations of Chronic Obstructive Pulmonary Disease? <i>Am J Respir Crit Care Med.</i> 2017; <b>196</b>(2): 139–149. <a target=xrefwindow id=d11674e996 href="http://www.ncbi.nlm.nih.gov/pubmed/27922741">PubMed Abstract </a> | <a target=xrefwindow id=d11674e999 href="https://doi.org/10.1164/rccm.201609-1794CI">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727083151">F1000 Recommendation</a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d11674e1012 class=n-a></a>Cazzola M, Calzetta L, Segreti A, <i> et al.</i>: Translational Study Searching for Synergy between Glycopyrronium and Indacaterol. <i>COPD.</i> 2015; <b>12</b>(2): 175–81. <a target=xrefwindow id=d11674e1023 href="http://www.ncbi.nlm.nih.gov/pubmed/25222881">PubMed Abstract </a> | <a target=xrefwindow id=d11674e1026 href="https://doi.org/10.3109/15412555.2014.922172">Publisher Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d11674e1035 class=n-a></a>Cazzola M, Calzetta L, Ora J, <i> et al.</i>: Searching for the synergistic effect between aclidinium and formoterol: From bench to bedside. <i>Respir Med.</i> 2015; <b>109</b>(10): 1305–11. <a target=xrefwindow id=d11674e1046 href="http://www.ncbi.nlm.nih.gov/pubmed/26303336">PubMed Abstract </a> | <a target=xrefwindow id=d11674e1049 href="https://doi.org/10.1016/j.rmed.2015.08.005">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d11674e1058 class=n-a></a>Cazzola M, Calzetta L, Puxeddu E, <i> et al.</i>: Pharmacological characterisation of the interaction between glycopyrronium bromide and indacaterol fumarate in human isolated bronchi, small airways and bronchial epithelial cells. <i>Respir Res.</i> 2016; <b>17</b>(1): 70. <a target=xrefwindow id=d11674e1069 href="http://www.ncbi.nlm.nih.gov/pubmed/27296533">PubMed Abstract </a> | <a target=xrefwindow id=d11674e1072 href="https://doi.org/10.1186/s12931-016-0386-8">Publisher Full Text </a> | <a target=xrefwindow id=d11674e1076 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4906998">Free Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d11674e1085 class=n-a></a>Calzetta L, Rogliani P, Page C, <i> et al.</i>: Pharmacological characterization of the interaction between tiotropium bromide and olodaterol on human bronchi and small airways. <i>Pulm Pharmacol Ther.</i> 2019; <b>56</b>: 39–50. <a target=xrefwindow id=d11674e1096 href="http://www.ncbi.nlm.nih.gov/pubmed/30876907">PubMed Abstract </a> | <a target=xrefwindow id=d11674e1099 href="https://doi.org/10.1016/j.pupt.2019.03.004">Publisher Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d11674e1109 class=n-a></a>Cazzola M, Matera MG: POINT: Should LAMA/LABA Combination Therapy Be Used as Initial Maintenance Treatment for COPD? Yes. <i>Chest.</i> 2018; <b>154</b>(4): 746–748. <a target=xrefwindow id=d11674e1117 href="http://www.ncbi.nlm.nih.gov/pubmed/30290925">PubMed Abstract </a> | <a target=xrefwindow id=d11674e1120 href="https://doi.org/10.1016/j.chest.2018.06.022">Publisher Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718170810"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11674e1129 class=n-a></a>Nannini LJ, Poole P, Milan SJ, <i> et al.</i>: Combined corticosteroid and long-acting beta<sub>2</sub>-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease. <i>Cochrane Database Syst Rev.</i> 2013; (11): CD003794. <a target=xrefwindow id=d11674e1140 href="http://www.ncbi.nlm.nih.gov/pubmed/24214176">PubMed Abstract </a> | <a target=xrefwindow id=d11674e1143 href="https://doi.org/10.1002/14651858.CD003794.pub4">Publisher Full Text </a> | <a target=xrefwindow id=d11674e1147 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6485527">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718170810">F1000 Recommendation</a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d11674e1160 class=n-a></a>Nannini LJ, Cates CJ, Lasserson TJ, <i> et al.</i>: Combined corticosteroid and long-acting beta-agonist in one inhaler versus inhaled steroids for chronic obstructive pulmonary disease. <i>Cochrane Database Syst Rev.</i> 2007; (4): CD006826. <a target=xrefwindow id=d11674e1168 href="http://www.ncbi.nlm.nih.gov/pubmed/17943917">PubMed Abstract </a> | <a target=xrefwindow id=d11674e1171 href="https://doi.org/10.1002/14651858.CD006826">Publisher Full Text </a> | <a target=xrefwindow id=d11674e1174 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4069257">Free Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d11674e1183 class=n-a></a>Rodrigo GJ, Castro-Rodriguez JA, Plaza V: Safety and efficacy of combined long-acting beta-agonists and inhaled corticosteroids vs long-acting beta-agonists monotherapy for stable COPD: a systematic review. <i>Chest.</i> 2009; <b>136</b>(4): 1029–1038. <a target=xrefwindow id=d11674e1191 href="http://www.ncbi.nlm.nih.gov/pubmed/19633090">PubMed Abstract </a> | <a target=xrefwindow id=d11674e1194 href="https://doi.org/10.1378/chest.09-0821">Publisher Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733961540"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11674e1203 class=n-a></a>Agusti A, Fabbri LM, Singh D, <i> et al.</i>: Inhaled corticosteroids in COPD: friend or foe? <i>Eur Respir J.</i> 2018; <b>52</b>(6): pii: 1801219. <a target=xrefwindow id=d11674e1214 href="http://www.ncbi.nlm.nih.gov/pubmed/30190269">PubMed Abstract </a> | <a target=xrefwindow id=d11674e1217 href="https://doi.org/10.1183/13993003.01219-2018">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733961540">F1000 Recommendation</a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726909576"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11674e1230 class=n-a></a>Barnes PJ: Glucocorticosteroids. <i>Handb Exp Pharmacol.</i> 2017; <b>237</b>: 93–115. <a target=xrefwindow id=d11674e1238 href="http://www.ncbi.nlm.nih.gov/pubmed/27796513">PubMed Abstract </a> | <a target=xrefwindow id=d11674e1241 href="https://doi.org/10.1007/164_2016_62">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726909576">F1000 Recommendation</a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d11674e1255 class=n-a></a>Cazzola M, Dahl R: Inhaled combination therapy with long-acting beta<sub>2</sub>-agonists and corticosteroids in stable COPD. <i>Chest.</i> 2004; <b>126</b>(1): 220–37. <a target=xrefwindow id=d11674e1266 href="http://www.ncbi.nlm.nih.gov/pubmed/15249466">PubMed Abstract </a> | <a target=xrefwindow id=d11674e1269 href="https://doi.org/10.1378/chest.126.1.220">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d11674e1278 class=n-a></a>Calzetta L, Matera MG, Facciolo F, <i> et al.</i>: Beclomethasone dipropionate and formoterol fumarate synergistically interact in hyperresponsive medium bronchi and small airways. <i>Respir Res.</i> 2018; <b>19</b>(1): 65. <a target=xrefwindow id=d11674e1289 href="http://www.ncbi.nlm.nih.gov/pubmed/29650006">PubMed Abstract </a> | <a target=xrefwindow id=d11674e1292 href="https://doi.org/10.1186/s12931-018-0770-7">Publisher Full Text </a> | <a target=xrefwindow id=d11674e1296 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5897944">Free Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726360636"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11674e1305 class=n-a></a>Wedzicha JA, Banerji D, Chapman KR, <i> et al.</i>: Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD. <i>N Engl J Med.</i> 2016; <b>374</b>(23): 2222–34. <a target=xrefwindow id=d11674e1316 href="http://www.ncbi.nlm.nih.gov/pubmed/27181606">PubMed Abstract </a> | <a target=xrefwindow id=d11674e1319 href="https://doi.org/10.1056/NEJMoa1516385">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726360636">F1000 Recommendation</a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d11674e1332 class=n-a></a>Cazzola M, Rogliani P: LABA/LAMA combinations instead of LABA/ICS combinations may prevent or delay exacerbations of COPD in some patients. <i>Evid Based Med.</i> 2016; <b>21</b>(6): 222. <a target=xrefwindow id=d11674e1340 href="http://www.ncbi.nlm.nih.gov/pubmed/27634637">PubMed Abstract </a> | <a target=xrefwindow id=d11674e1343 href="https://doi.org/10.1136/ebmed-2016-110525">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733072244"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11674e1352 class=n-a></a>Lipson DA, Barnhart F, Brealey N, <i> et al.</i>: Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD. <i>N Engl J Med.</i> 2018; <b>378</b>(18): 1671–1680. <a target=xrefwindow id=d11674e1363 href="http://www.ncbi.nlm.nih.gov/pubmed/29668352">PubMed Abstract </a> | <a target=xrefwindow id=d11674e1366 href="https://doi.org/10.1056/NEJMoa1713901">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733072244">F1000 Recommendation</a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734037653"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11674e1379 class=n-a></a>Vestbo J, Fabbri L, Papi A, <i> et al.</i>: Inhaled corticosteroid containing combinations and mortality in COPD. <i>Eur Respir J.</i> 2018; <b>52</b>(6): pii: 1801230. <a target=xrefwindow id=d11674e1390 href="http://www.ncbi.nlm.nih.gov/pubmed/30209195">PubMed Abstract </a> | <a target=xrefwindow id=d11674e1393 href="https://doi.org/10.1183/13993003.01230-2018">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734037653">F1000 Recommendation</a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d11674e1407 class=n-a></a>Cazzola M, Rogliani P, Matera MG: Double or Triple Therapy in Chronic Obstructive Pulmonary Disease. <i>BRN.</i> 2018; <b>4</b>(4): 287–303. <a target=xrefwindow id=d11674e1415 href="https://doi.org/10.23866/BRNRev:2017-0029">Publisher Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d11674e1424 class=n-a></a>Cazzola M, Rogliani P, Calzetta L, <i> et al.</i>: Triple therapy <i>versus</i> single and dual long-acting bronchodilator therapy in COPD: a systematic review and meta-analysis. <i>Eur Respir J.</i> 2018; <b>52</b>(6): pii: 1801586. <a target=xrefwindow id=d11674e1438 href="http://www.ncbi.nlm.nih.gov/pubmed/30309975">PubMed Abstract </a> | <a target=xrefwindow id=d11674e1442 href="https://doi.org/10.1183/13993003.01586-2018">Publisher Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734663464"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11674e1451 class=n-a></a>Leung JM, Sin DD: Inhaled corticosteroids in COPD: the final verdict is…. <i>Eur Respir J.</i> 2018; <b>52</b>(6): pii: 1801940. <a target=xrefwindow id=d11674e1459 href="http://www.ncbi.nlm.nih.gov/pubmed/30545961">PubMed Abstract </a> | <a target=xrefwindow id=d11674e1462 href="https://doi.org/10.1183/13993003.01940-2018">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734663464">F1000 Recommendation</a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d11674e1475 class=n-a></a>Calzetta L, Cazzola M, Matera MG, <i> et al.</i>: Adding a LAMA to ICS/LABA Therapy: A Meta-analysis of Triple Combination Therapy in COPD. <i>Chest.</i> 2019; <b>155</b>(4): 758–770. <a target=xrefwindow id=d11674e1486 href="http://www.ncbi.nlm.nih.gov/pubmed/30660781">PubMed Abstract </a> | <a target=xrefwindow id=d11674e1489 href="https://doi.org/10.1016/j.chest.2018.12.016">Publisher Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732949526"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11674e1498 class=n-a></a>Calverley PMA, Anzueto AR, Carter K, <i> et al.</i>: Tiotropium and olodaterol in the prevention of chronic obstructive pulmonary disease exacerbations (DYNAGITO): a double-blind, randomised, parallel-group, active-controlled trial. <i>Lancet Respir Med.</i> 2018; <b>6</b>(5): 337–344. <a target=xrefwindow id=d11674e1509 href="http://www.ncbi.nlm.nih.gov/pubmed/29605624">PubMed Abstract </a> | <a target=xrefwindow id=d11674e1512 href="https://doi.org/10.1016/S2213-2600(18)30102-4">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732949526">F1000 Recommendation</a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d11674e1525 class=n-a></a>Rogliani P, Calzetta L, Cazzola M: Is ICS-LAMA an alternative option to treat patients with COPD? <i>Lancet Respir Med.</i> 2018; <b>6</b>(5): 316–317. <a target=xrefwindow id=d11674e1533 href="http://www.ncbi.nlm.nih.gov/pubmed/29605621">PubMed Abstract </a> | <a target=xrefwindow id=d11674e1536 href="https://doi.org/10.1016/S2213-2600(18)30139-5">Publisher Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d11674e1546 class=n-a></a>Cazzola M, Calzetta L, Rogliani P, <i> et al.</i>: Interaction between corticosteroids and muscarinic antagonists in human airways. <i>Pulm Pharmacol Ther.</i> 2016; <b>36</b>: 1–9. <a target=xrefwindow id=d11674e1557 href="http://www.ncbi.nlm.nih.gov/pubmed/26656790">PubMed Abstract </a> | <a target=xrefwindow id=d11674e1560 href="https://doi.org/10.1016/j.pupt.2015.11.004">Publisher Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725357903"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11674e1569 class=n-a></a>Martinez FJ, Calverley PM, Goehring UM, <i> et al.</i>: Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial. <i>Lancet.</i> 2015; <b>385</b>(9971): 857–66. <a target=xrefwindow id=d11674e1580 href="http://www.ncbi.nlm.nih.gov/pubmed/25684586">PubMed Abstract </a> | <a target=xrefwindow id=d11674e1583 href="https://doi.org/10.1016/S0140-6736(14)62410-7">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725357903">F1000 Recommendation</a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d11674e1596 class=n-a></a>Rogliani P, Calzetta L, Cazzola M, <i> et al.</i>: Drug safety evaluation of roflumilast for the treatment of COPD: a meta-analysis. <i>Expert Opin Drug Saf.</i> 2016; <b>15</b>(8): 1133–46. <a target=xrefwindow id=d11674e1607 href="http://www.ncbi.nlm.nih.gov/pubmed/27279341">PubMed Abstract </a> | <a target=xrefwindow id=d11674e1610 href="https://doi.org/10.1080/14740338.2016.1199683">Publisher Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d11674e1619 class=n-a></a>Cazzola M, Calzetta L, Rogliani P, <i> et al.</i>: The discovery of roflumilast for the treatment of chronic obstructive pulmonary disease. <i>Expert Opin Drug Discov.</i> 2016; <b>11</b>(7): 733–44. <a target=xrefwindow id=d11674e1630 href="http://www.ncbi.nlm.nih.gov/pubmed/27169612">PubMed Abstract </a> | <a target=xrefwindow id=d11674e1633 href="https://doi.org/10.1080/17460441.2016.1184642">Publisher Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734035850"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11674e1642 class=n-a></a>Rabe KF, Watz H, Baraldo S, <i> et al.</i>: Anti-inflammatory effects of roflumilast in chronic obstructive pulmonary disease (ROBERT): a 16-week, randomised, placebo-controlled trial. <i>Lancet Respir Med.</i> 2018; <b>6</b>(11): 827–836. <a target=xrefwindow id=d11674e1653 href="http://www.ncbi.nlm.nih.gov/pubmed/30224319">PubMed Abstract </a> | <a target=xrefwindow id=d11674e1656 href="https://doi.org/10.1016/S2213-2600(18)30331-X">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734035850">F1000 Recommendation</a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d11674e1669 class=n-a></a>Barnes PJ: Theophylline. <i>Am J Respir Crit Care Med.</i> 2013; <b>188</b>(8): 901–6. <a target=xrefwindow id=d11674e1677 href="http://www.ncbi.nlm.nih.gov/pubmed/23672674">PubMed Abstract </a> | <a target=xrefwindow id=d11674e1680 href="https://doi.org/10.1164/rccm.201302-0388PP">Publisher Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d11674e1690 class=n-a></a>Horita N, Miyazawa N, Kojima R, <i> et al.</i>: Chronic Use of Theophylline and Mortality in Chronic Obstructive Pulmonary Disease: A Meta-analysis. <i>Arch Bronconeumol.</i> 2016; <b>52</b>(5): 233–8. <a target=xrefwindow id=d11674e1701 href="http://www.ncbi.nlm.nih.gov/pubmed/26612542">PubMed Abstract </a> | <a target=xrefwindow id=d11674e1704 href="https://doi.org/10.1016/j.arbres.2015.02.021">Publisher Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d11674e1713 class=n-a></a>Matera MG, Page C, Cazzola M: Doxofylline is not just another theophylline! <i>Int J Chron Obstruct Pulmon Dis.</i> 2017; <b>12</b>: 3487–3493. <a target=xrefwindow id=d11674e1721 href="http://www.ncbi.nlm.nih.gov/pubmed/29255355">PubMed Abstract </a> | <a target=xrefwindow id=d11674e1724 href="https://doi.org/10.2147/COPD.S150887">Publisher Full Text </a> | <a target=xrefwindow id=d11674e1727 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5723117">Free Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d11674e1736 class=n-a></a>Cazzola M, Calzetta L, Barnes PJ, <i> et al.</i>: Efficacy and safety profile of xanthines in COPD: a network meta-analysis. <i>Eur Respir Rev.</i> 2018; <b>27</b>(148): pii: 180010. <a target=xrefwindow id=d11674e1747 href="http://www.ncbi.nlm.nih.gov/pubmed/29720510">PubMed Abstract </a> | <a target=xrefwindow id=d11674e1750 href="https://doi.org/10.1183/16000617.0010-2018">Publisher Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d11674e1759 class=n-a></a>Kanoh S, Rubin BK: Mechanisms of action and clinical application of macrolides as immunomodulatory medications. <i>Clin Microbiol Rev.</i> 2010; <b>23</b>(3): 590–615. <a target=xrefwindow id=d11674e1767 href="http://www.ncbi.nlm.nih.gov/pubmed/20610825">PubMed Abstract </a> | <a target=xrefwindow id=d11674e1770 href="https://doi.org/10.1128/CMR.00078-09">Publisher Full Text </a> | <a target=xrefwindow id=d11674e1773 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2901655">Free Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725404799"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11674e1782 class=n-a></a>Ni W, Shao X, Cai X, <i> et al.</i>: Prophylactic use of macrolide antibiotics for the prevention of chronic obstructive pulmonary disease exacerbation: a meta-analysis. <i>PLoS One.</i> 2015; <b>10</b>(3): e0121257. <a target=xrefwindow id=d11674e1793 href="http://www.ncbi.nlm.nih.gov/pubmed/25812085">PubMed Abstract </a> | <a target=xrefwindow id=d11674e1796 href="https://doi.org/10.1371/journal.pone.0121257">Publisher Full Text </a> | <a target=xrefwindow id=d11674e1800 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4374882">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725404799">F1000 Recommendation</a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d11674e1813 class=n-a></a>Cazzola M, Calzetta L, Rogliani P, <i> et al.</i>: The Challenges of Precision Medicine in COPD. <i>Mol Diagn Ther.</i> 2017; <b>21</b>(4): 345–355. <a target=xrefwindow id=d11674e1824 href="http://www.ncbi.nlm.nih.gov/pubmed/28247183">PubMed Abstract </a> | <a target=xrefwindow id=d11674e1827 href="https://doi.org/10.1007/s40291-017-0266-z">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d11674e1837 class=n-a></a>Rogliani P, Matera MG, Page C, <i> et al.</i>: Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine. <i>Respir Res.</i> 2019; <b>20</b>(1): 104. <a target=xrefwindow id=d11674e1848 href="http://www.ncbi.nlm.nih.gov/pubmed/31133026">PubMed Abstract </a> | <a target=xrefwindow id=d11674e1851 href="https://doi.org/10.1186/s12931-019-1078-y">Publisher Full Text </a> | <a target=xrefwindow id=d11674e1855 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6537173">Free Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d11674e1864 class=n-a></a>Cazzola M, Calzetta L, Page C, <i> et al.</i>: Thiol-Based Drugs in Pulmonary Medicine: Much More than Mucolytics. <i>Trends Pharmacol Sci.</i> 2019; <b>40</b>(7): 452–463. <a target=xrefwindow id=d11674e1875 href="http://www.ncbi.nlm.nih.gov/pubmed/31147200">PubMed Abstract </a> | <a target=xrefwindow id=d11674e1878 href="https://doi.org/10.1016/j.tips.2019.04.015">Publisher Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d11674e1887 class=n-a></a>Rahman I, MacNee W: Antioxidant pharmacological therapies for COPD. <i>Curr Opin Pharmacol.</i> 2012; <b>12</b>(3): 256–65. <a target=xrefwindow id=d11674e1895 href="http://www.ncbi.nlm.nih.gov/pubmed/22349417">PubMed Abstract </a> | <a target=xrefwindow id=d11674e1898 href="https://doi.org/10.1016/j.coph.2012.01.015">Publisher Full Text </a> | <a target=xrefwindow id=d11674e1901 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3768007">Free Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d11674e1910 class=n-a></a>Cazzola M, Calzetta L, Facciolo F, <i> et al.</i>: Pharmacological investigation on the anti-oxidant and anti-inflammatory activity of N-acetylcysteine in an <i>ex vivo</i> model of COPD exacerbation. <i>Respir Res.</i> 2017; <b>18</b>(1): 26. <a target=xrefwindow id=d11674e1924 href="http://www.ncbi.nlm.nih.gov/pubmed/28118826">PubMed Abstract </a> | <a target=xrefwindow id=d11674e1928 href="https://doi.org/10.1186/s12931-016-0500-y">Publisher Full Text </a> | <a target=xrefwindow id=d11674e1931 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5260037">Free Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d11674e1940 class=n-a></a>Cazzola M, Matera MG: Editorial overview: Respiratory: Pulmonary pharmacology - It is time for a breath of fresh air. <i>Curr Opin Pharmacol.</i> 2018; <b>40</b>: iv–viii. <a target=xrefwindow id=d11674e1948 href="http://www.ncbi.nlm.nih.gov/pubmed/29859765">PubMed Abstract </a> | <a target=xrefwindow id=d11674e1951 href="https://doi.org/10.1016/j.coph.2018.05.011">Publisher Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d11674e1960 class=n-a></a>Cazzola M, Matera MG: Bronchodilators: current and future. <i>Clin Chest Med.</i> 2014; <b>35</b>(1): 191–201. <a target=xrefwindow id=d11674e1968 href="http://www.ncbi.nlm.nih.gov/pubmed/24507846">PubMed Abstract </a> | <a target=xrefwindow id=d11674e1971 href="https://doi.org/10.1016/j.ccm.2013.10.005">Publisher Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d11674e1981 class=n-a></a>Cazzola M, Page C: Long-acting bronchodilators in COPD: Where are we now and where are we going? <i>Breathe.</i> 2014; <b>10</b>: 110–120. <a target=xrefwindow id=d11674e1989 href="https://doi.org/10.1183/20734735.014813">Publisher Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d11674e1998 class=n-a></a>Matera MG, Page C, Rogliani P, <i> et al.</i>: Therapeutic Monoclonal Antibodies for the Treatment of Chronic Obstructive Pulmonary Disease. <i>Drugs.</i> 2016; <b>76</b>(13): 1257–1270. <a target=xrefwindow id=d11674e2009 href="http://www.ncbi.nlm.nih.gov/pubmed/27506851">PubMed Abstract </a> | <a target=xrefwindow id=d11674e2012 href="https://doi.org/10.1007/s40265-016-0625-9">Publisher Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/735287766"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11674e2021 class=n-a></a>McDonald VM, Fingleton J, Agusti A, <i> et al.</i>: Treatable traits: a new paradigm for 21st century management of chronic airway diseases: Treatable Traits Down Under International Workshop report. <i>Eur Respir J.</i> 2019; <b>53</b>(5): pii: 1802058. <a target=xrefwindow id=d11674e2032 href="http://www.ncbi.nlm.nih.gov/pubmed/30846468">PubMed Abstract </a> | <a target=xrefwindow id=d11674e2035 href="https://doi.org/10.1183/13993003.02058-2018">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/735287766">F1000 Recommendation</a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727606021"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11674e2048 class=n-a></a>Shrimanker R, Choo XN, Pavord ID: A new approach to the classification and management of airways diseases: identification of treatable traits. <i>Clin Sci (Lond).</i> 2017; <b>131</b>(10): 1027–1043. <a target=xrefwindow id=d11674e2056 href="http://www.ncbi.nlm.nih.gov/pubmed/28487412">PubMed Abstract </a> | <a target=xrefwindow id=d11674e2059 href="https://doi.org/10.1042/CS20160028">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727606021">F1000 Recommendation</a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d11674e2072 class=n-a></a>Cazzola M, Rogliani P, Ora J, <i> et al.</i>: Treatment options for moderate-to-very severe chronic obstructive pulmonary disease. <i>Expert Opin Pharmacother.</i> 2016; <b>17</b>(7): 977–88. <a target=xrefwindow id=d11674e2083 href="http://www.ncbi.nlm.nih.gov/pubmed/26894516">PubMed Abstract </a> | <a target=xrefwindow id=d11674e2086 href="https://doi.org/10.1517/14656566.2016.1155555">Publisher Full Text </a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 29 Aug 2019</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/8-1533/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/8-1533/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Unit of Respiratory Medicine, Department of Experimental Medicine, University of Rome &quot;Tor Vergata&quot;, Rome, Italy<br/> <sup>2</sup> Clinic of Respiratory Medicine and Pulmonary Cell Research, University Hospital of Basel, Basel, Switzerland<br/> <sup>3</sup> Unit of Pharmacology, Department of Experimental Medicine, University of Campania &quot;Luigi Vanvitelli&quot;, Naples, Italy<br/> <p> <div class=margin-bottom> Mario Cazzola <br/> <span>Roles: </span> Conceptualization, Writing – Original Draft Preparation </div> <div class=margin-bottom> Paola Rogliani <br/> <span>Roles: </span> Conceptualization, Writing – Review & Editing </div> <div class=margin-bottom> Daiana Stolz <br/> <span>Roles: </span> Conceptualization, Writing – Review & Editing </div> <div class=margin-bottom> Maria Gabriella Matera <br/> <span>Roles: </span> Conceptualization, Writing – Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/8-1533/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 29 Aug 2019, 8:1533 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.19811.1">https://doi.org/10.12688/f1000research.19811.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2019 Cazzola M <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=21732 data-id=19811 data-downloads="" data-views="" data-scholar="10.12688/f1000research.19811.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/8-1533/v1/pdf?article_uuid=099d25f3-2c3b-4dfb-846f-f95ebe5d5b89" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.19811.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Cazzola M, Rogliani P, Stolz D and Matera MG. Pharmacological treatment and current controversies in COPD [version 1; peer review: 3 approved] <i>F1000Research</i> 2019, <b>8</b>(F1000 Faculty Rev):1533 (<a href="https://doi.org/10.12688/f1000research.19811.1" target=_blank>https://doi.org/10.12688/f1000research.19811.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=19811 id=mobile-track-article-signin-19811 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/19811?target=/articles/8-1533/v1"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=21732 /> <input name=articleId type=hidden value=19811 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Reynold Panettieri</strong>, Rutgers Institute for Translational Medicine & Science, Rutgers University, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Omar S. Usmani</strong>, National Heart and Lung Institute, Imperial College London, UK </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Masakazu Ichinose</strong>, Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Japan </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 29 Aug 2019</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/8-1533/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/8-1533/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=55794-52745></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=32565-52747></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=55793-52746></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=3><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> <th class="c-report-timeline__headings-version p-article__color--dark">3</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/8-1533/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>29 Aug 19</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Reynold Panettieri</strong>, Rutgers Institute for Translational Medicine & Science, Rutgers University, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Omar S. Usmani</strong>, National Heart and Lung Institute, Imperial College London, UK </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Masakazu Ichinose</strong>, Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Japan </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/8-1533/v1&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/8-1533/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Pharmacological treatment and current controversies...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/8-1533/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/8-1533/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/8-1533/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Cazzola M et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/8-1533/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/8-1533",
            templates : {
                twitter : "Pharmacological treatment and current controversies in COPD. Cazzola M et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/8-1533/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Pharmacological treatment and current controversies in COPD", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Pharmacological treatment and current controversies in COPD", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/19811/21732")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "21732");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "52745": 0,
                           "52746": 0,
                           "52747": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "11d380be-3e02-41bf-a902-2537748823c5";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/8-1533.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/8-1533.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/8-1533.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/8-1533.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/8-1533.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>